research and development
PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
September 12, 2025Innovation Award 2025, PlasmidFactory, cell and gene therapy, medical communications, research and development
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with the Innovation Award 2025 of …
Richmond Pharmacology promotes Patrick Ramiah to Director
September 8, 2025Clinical Trial Services, Director of Clinical Project Delivery & Operational Excellence, Richmond Pharmacology, corporate, research and development
Patrick Ramiah has been promoted to Director of Clinical Project Delivery & Operational Excellence at Richmond Pharmacology, effective from 1 …
AAX Biotech announces collaboration for cardiovascular antibody therapy
May 8, 2025Research and Development AAX Biotech, Cardiology, antibody therapies, collaboration, research and development
Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of antibody-based therapies targeting cardiovascular disease. …
Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months
April 10, 2025Research and Development Alzheimer's disease, Neurology, TauRx Pharmaceutics, research and development
TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the progression of Alzheimer’s disease over …
Enosium Life Science acquires RWEality
April 3, 2025Business Services, Consultancy Consultancy, Corporate, Enosium Life Sciences, RWEality, acquisition, life sciences, research and development
Enosium Life Science, which specialises in life sciences, has acquired RWEality, a consultancy focused on public policies, technology and healthcare …
Usama Dar appointed as chief product and technology officer at CluePoints
April 2, 2025Research and Development Pharmacy, clinical trial analysis, cluepoints, pharma, research and development
CluePoints has appointed Usama Dar as its new chief product and technology officer, effective 1 April 2025. This follows Dar’s …
Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial
April 1, 2025Research and Development Cardiology, Novo Nordisk, cardiometabolic diseases, research and development
Novo Nordisk announced results from its SOUL cardiovascular outcomes trial. Rybelsus (oral semaglutide) significantly reduced the risk of major adverse …
Corcept’s relacorilant trial in patients with platinum-resistant ovarian cancer meets primary endpoint
April 1, 2025Research and Development Corcept Therapeutics, Oncology, ovarian cancer, research and development
Corcept Therapeutics announced that relacorilant plus nab-paclitaxel met its primary endpoint of improved progression-free survival in ROSELLA, the company’s phase …
Secarna Pharmaceuticals to announce positive new data at cancer research conference
April 1, 2025Research and Development Oncology, Secarna Pharmaceuticals, oncology, research and development
Secarna Pharmaceuticals will present new preclinical data with its lead programme SECN-15 at the American Association for Cancer Research (AACR) …
Research collaboration announced between Oxford University and GSK
January 27, 2025Research and Development Cancer, Oncology, Oxford University, neoantigens, partnership, research and development
The GSK-Oxford Cancer Immuno-Prevention Programme was announced at the end of January and will focus on researching the prevention of …
NMD Pharma’s Charcot-Marie-Tooth disease treatment granted ODD by FDA
January 6, 2025CMT, FDA, NMD Pharma, Orphan Drugs, Pain, nervous system, research and development
Biotech company NMD Pharma has announced that the US Food and Drug Association (FDA) have granted its Charcot-Marie-Tooth (CMT) disease …
Merck KGaA announces new Senior Vice President, Head of Global Affairs
July 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Maria Rivas, Germany, Merck, Merck KGaA, research and development
Merck KGaA has announced the appointment of Dr Maria Rivas as Senior Vice President, Head of Global Affairs. Dr Rivas, …
Gilead quietly drops drugs from line up alongide Q3 results
November 2, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abzena, Gilead, research and development
Gilead Sciences followed Pfizer in discreetly dropping a drug alongside its third quarter profit reports. The drug in question, for …
Heart disease drug development is falling
August 30, 2016Manufacturing and Production, Research and Development cardiovascular disease, heart disease, research and development
The number of drugs currently in development to combat heart disease has fallen in the last 20 years, it has …
Eli Lilly showcases emerging pipeline to investors
May 25, 2016Research and Development Eli Lilly, investors, lilly, pipeline, research and development
Eli Lilly and Co (NYSE: LLY) has showcased its emerging pipeline to potential investors, highlighting its potential to launch 20 …
